KLKBF yields 2.42% · JNJ yields 3.36%● Live data
📍 KLKBF pulled ahead of the other in Year 1
Combined, KLKBF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KLKBF + JNJ for your $10,000?
Kuala Lumpur Kepong Berhad engages in the plantation, manufacturing, and property development businesses. The company operates through Plantation, Manufacturing, Property Development, Investment Holding, and Others segments. It is involved in the cultivation, processing, and marketing of palm and rubber products; extraction of crude palm oil; refining of palm products; kernel crushing and trading of palm products; manufacturing and trading in oleochemicals, fatty acids, glycerin, industrial amides, fatty alcohol and methyl esters, non-ionic surfactants and esters, soap noodles, triacetin, special paper chemicals and surfactants, and palm phytonutrients and other palm derivatives; detergents, auxiliary materials for detergents and cosmetics, and basic organic chemicals from agricultural products; and alcohol ether sulphates, alcohol sulphates, and sulphonic acids. The company also provides rubber gloves, parquet flooring products, pharmaceutical and bio-pharmaceutical intermediates, and fine chemicals, as well as stores and distributes bulk liquid. In addition, it engages in farming and management services; and agronomic service and research, as well as operates biogas power plants; and develops residential and commercial properties. Further, the company operates holiday bungalows; manages properties; manufactures jams and preserves; and offers offshore captive insurance and logistics services related to palm products. It operates in Malaysia, Far East, the Middle East, South East Asia, Southern Asia, Europe, North America, South America, Australia, Africa, and internationally. The company was founded in 1906 and is based in Ipoh, Malaysia.
Full KLKBF Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.